Chemical Compound
Anhydrodihydroartemisinin
CAS Registry Number
82596-30-3
Primary Record
Anhydrodihydroartemisinin
- In stock
- 3,489 g
- Purity
- 99.5 %
- CAS
- 82596-30-3
Compound Identifiers & Properties
- CAS
- 82596-30-3
- PubChem CID
- 393517
- SMILES
- C[C@@H]1CC[C@H]2C(=CO[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)C
- Canonical SMILES
- CC1=CO[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3
Names & Synonyms
- Anhydrodihydroartemisinin
- Anhydrodihydroartemisnin
- Anhydro Dihydro Artemisinin
- trimethyl[?]
- 9,10-Anhydrodehydroartemisinin
- 82596-30-3
- Artesunate related compound C
- Anhydrodihydro artemisinin
- Artemisinin Impurity 29
- Artemisinin, anhydrodihydro-
- RefChem:915872
- 0YH8NQO930
- UNII-0YH8NQO930
- 9,10-Anhydro-10-deoxoartemisinin
- 9,10-Dehydrodeoxyartemisinin
- DTXSID50327855
- AC1L96B0
- CHEMBL279307
- orb1984272
- CTK8C8741
- DTXCID20278966
- NSC695575
- UKXCIQFCSITOCY-VLDCTWHGSA-N
- C15H22O4
- Artemisinin Anhydro Dihydro Impurity
- (+)-9,10-Anhydrodehydroartemisinin
- CID393517
- ZINC28536638
- (+)-9,10-Anhydro dehydroartemisinin
- AKOS040760837
- FA17928
- NSC-695575
- J608.402H
- CS-0149098
- FT-0662190
- (1R,4S,5R,8S,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadec-9-ene
- Q27237351
- (3R,5aS,6R,8aS,12R,12aR)-3,4,5,5a,6,7,8,8a-Octahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin(+)-9,10
- 3,12-Epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin, 3,4,5,5a,6,7,8,8a-octahydro-3,6,9-trimethyl-, (3R,5aS,6R,8aS,12R,12aR)-
- (3R,5aS,6R,8aS,12R,12aR)-3,6,9-Trimethyl-4,5,5a,6,7,8,8a,12-octahydro-3H-3,12-epoxy[1,2]dioxepino[4,3-i]isochromene
- (3R,5aS,6R,8aS,12R,12aR)-3,4,5,5a,6,7,8,8a-Octahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin
- (1R,4S,5R,8S,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo(10.3.1.04,13.08,13)hexadec-9-ene
- (1R,4S,5R,8S,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.0?,??.0?,??]hexadec-9-ene
- (3aS)-3,6beta,9-Trimethyl-9beta,10bbeta-epidioxy-3abeta,4,5,6,6abeta,7,8,9,10aalpha,10b-decahydro-1,10-dioxacyclohepta[de]naphthalene
- (3R,12aR)-3,4,5,5aalpha,6,7,8,8aalpha-Octahydro-3,6alpha,9-trimethyl-3beta,12alpha-epoxypyrano[4,3-j]-1,2-benzodioxepin
- (3R,12aR)-3,6alpha,9-Trimethyl-3beta,12alpha-epoxy-3,4,5,5aalpha,6,7,8,8aalpha-octahydropyrano[4,3-j]-1,2-benzodioxepin
- (3R,12aR)-3,6alpha,9beta-Trimethyl-3beta,12alpha-epoxy-3,4,5,5aalpha,6,7,8,8aalpha-octahydropyrano[4,3-j]-1,2-benzodioxepin
- (3R,12R,12aR)-3,4,5,5aalpha,6,7,8,8aalpha-Octahydro-3,6alpha,9-trimethyl-3,12-epoxypyrano[4,3-j]-1,2-benzodioxepin
- (3R,5aS,6R,8aS,12R,12aR)-3,4,5,5a,6,7,8,8a-Octahydro-3,6,9-trimethyl--3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin; (+)-9,10-Anhydrodehydroartemisinin; 9,10-Anhydro-10-deoxoartemisinin; 9,10-Anhydrodehydroartemisinin; Anhydrodihydroartemisinin; Anhydrodihydroartemisnin; 3, 2-Epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin, 3,4,5,5a,6,7,8,8a-octahydro-3,6,9-trimethyl-, [3R-(3alpha,5abeta,6beta,8abeta,12beta,12aR*)]-; Artesunate Related Compound C
- (3R,5aS,6R,8aS,12R,12aR)-3,6,9-trimethyl-3,4,5,5a,6,7,8,8a-octahydro-12H-3,12-epoxy[1,2]dioxepino[4,3-i]isochromene
- (3R,5aS,6R,8aS,12R,12aR)-3,6,9-Trimethyl-3,4,5,5a,6,7,8,8a-octahydro-12H-3,12-epoxypyrano[4,3-j][1,2]benzodioxepine
- (3r,5as,6r,8as,12r,12ar)-3,6,9-trimethyl-3,4,5,5a,6,7,8,8a-octahydro-3,12-epoxy[1,2]dioxepino[4,3-i]isochromene
- 3,6beta,9-Trimethyl-9beta,10bbeta-epidioxy-3abeta,4,5,6,6abeta,7,8,9,10aalpha,10b-decahydropyrano[4,3,2-jk][2]benzoxepin
- 3R,5aS,6R,8aS,12R,12aR)-3,4,5,5a,6,7,8,8a-octahydro-3,6,9-trimethyl-3,12-epoxy-12Hpyrano[4,3-j]-1,2-benzodioxepin